Al Jazeera examines the toll pneumonia and diarrhea take on children living in developing countries and how the GAVI Alliance is working to help improve health outcomes among children through the distribution of pneumonia vaccines around the world.
Private Sector Involvement
In conjunction with the state visit to the U.S. by Chinese President Hu Jintao, the U.S. Department of Health and Human Services (HHS) and several other federal agencies on Wednesday announced a new public-private health care partnership between the U.S. and China, Modern Healthcare reports (Blesch, 1/19).
“A joint venture between U.S. drugmaker Merck and Britain’s Wellcome Trust charity said on Monday it is working on an oral rotavirus vaccine designed to be cheaper and easier to use than current shots,” Reuters reports. “Hilleman Laboratories, an India-based joint venture set up on a not-for-profit basis in 2009, said the vaccine will aim to protect against diarrhea-causing rotavirus infections and will be based on thin strips or granules that dissolve in the mouth and can be easily transported, stored and administered.”
Also In Global Health News: HP/NGO Partnership; Polio Vaccination Campaign In Pakistan; Disaster Deaths; Pediatric AIDS Program In Zimbabwe
HP Partners With South African NGO In New Type Of Collaboration “Hewlett-Packard is reshaping its policies on giving away money to nonprofit causes. Now the company will not just give away money. It will also donate the expertise of its employees to build solutions for nonprofits,” VentureBeat reports. Paul Ellingstad,…
Innovative Health Financing Can Benefit Global Health, Pharma: “The launch of pneumococcal vaccination in Nicaragua under AMC [advance market commitment] has shown that innovative approaches to health financing can benefit both global health and pharmaceutical companies,” according toÂ a Lancet Infectious Diseases editorial that describes how the roll-out of GAVI initiative…
Johnson & Johnson’s Tibotec Pharmaceuticals unit on Thursday announced it granted multiple licenses to generic drug manufacturers” to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if itâ€™s approved by regulators,” Bloomberg Businessweek reports.
Stockpiling Flu Drugs, Vaccines Reduces Impact Of Pandemic, But Option Out Of Reach For Most Countries, Study Finds
“Stockpiling antiviral flu drugs and vaccines saves lives and reduces disease in a flu pandemic,” but the cost to maintain such a stockpile and deploy interventions in the event of an outbreak “is too expensive for around two thirds of the world’s population, scientists said on Wednesday,” Reuters reports.
Also In Global Health News: Reproductive Health In Philippines; Microfinance Debt In India; HIV/AIDS In Kenya; Google’s DotOrg
Reproductive Health Bill Is Approved By Philippines House Of Representatives IRIN reports a “hotly debated”Â bill “that proposes national funding for, and access to, reproductive healthcare services and products,” cleared “a major hurdle on [Monday] after being approved by a committee of the Philippines House of Representatives” (2/1). Biliran Rep. Rogelio…
On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).
“A rise in global funding for research into neglected diseases needs to be matched by a continued focus on delivering practical new ways to curb sickness in the developing world,” according to the third annual report by the Global Funding of Innovation for Neglected Diseases (G-FINDER) released on Wednesday, Reuters reports.